Certification organization and professional society for allied health personnel
Legislation affecting payment for clinical laboratory diagnostic tests, including but not limited to COVID-19 tests; Promote legislative amendments to section 216 of the Protecting Access to Medicare Act of 2014 (PAMA) to implement Medicare Payment Advisory Commission (MedPAC) recommendations to Congress on prospective improvements to methodologies for market pricing of the Medicare Clinical Laboratory Fee Schedule; support legislation to delay fee schedule reductions and data reporting under PAMA sec. 216. Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128.
MMM - Medicare/Medicaid MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
MICHAEL N. MCCARTY LAW OFFICE PLLC
1050 30th Street NW, Washington, DC, 20007, US
MICHAEL N MCCARTY MICHAEL N MCCARTY